Alar Pharmaceuticals Inc (6785)

Alar Pharmaceuticals Inc stock price live, this page displays TWO 6785 stock exchange data. View the 6785 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Alar Pharmaceuticals Inc real time stock price chart below.

What Is the Alar Pharmaceuticals Inc Stock Price Today?
The Alar Pharmaceuticals Inc stock price today is 84.00.

What Is the Stock Symbol for Alar Pharmaceuticals Inc?
The stock symbol for Alar Pharmaceuticals Inc is "6785."

What Stock Exchange Does Alar Pharmaceuticals Inc Trade On?
Alar Pharmaceuticals Inc is listed and trades on the TPEX stock exchange.

Is Alar Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Alar Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.

You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6785 quote. (ISIN: TW0006785009)

TPEX

Currency in TWD

84.00

-1.00(-1.18%)

Closed·30/10

Fair Value

Unlock Value

Day's Range

82.00

85.00

52 wk Range

82.00

87.50

Trading near 52-week Low

1/3

Trading near 52-week Low

1/3

Earnings results expected in 0 days

1/3

6785 is not included in our AI-picked strategies. See which stocks are.

1/3

6785 Scorecard

Company’s Health

Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.

Unlock

Fair Value

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.

Unlock Price

Fair Price

Upside

Technical Analysis

Currently not supported.

Analysts Sentiment

Currently not supported.

Members' Sentiments

Bearish

Bullish

ProTips

Tips that distill complex financial data into concise, actionable investment insights.

Unlock All 8

Impressive gross profit margins

Fair Value

Unlock Value

Day's Range

82.0085.00

52 wk Range

82.0087.50

Key Statistics

Edit

More metrics for 6785

Prev. Close

Open

Day's Range

82-85

52 wk Range

82-87.5

Volume

25.64K

Average Volume (3m)

1-Year Change

Book Value / Share

Fair Value

Fair Value Upside

Market Cap

Shares Outstanding

Revenue

Net Income

EPS

EPS Growth Forecast

Next Earnings Date

Dividend (Yield)

Dividends Payment Streak

Unlock

RSI(14)

37.52

P/E Ratio

Return on Assets

Return on Equity

Gross Profit Margin

Price/Book

EBITDA

EV/EBITDA

Beta

ISIN

TW0006785009

More metrics for 6785

Prev. Close

Open

Day's Range

82-85

52 wk Range

82-87.5

Volume

25.64K

Average Volume (3m)

1-Year Change

Book Value / Share

Fair Value

Fair Value Upside

Market Cap

Shares Outstanding

Revenue

Net Income

EPS

EPS Growth Forecast

Next Earnings Date

Dividend (Yield)

Dividends Payment Streak

Unlock

RSI(14)

37.52

P/E Ratio

Return on Assets

Return on Equity

Gross Profit Margin

Price/Book

EBITDA

EV/EBITDA

Beta

ISIN

TW0006785009

More metrics for 6785

Prev. Close

Open

Day's Range

82-85

52 wk Range

82-87.5

Volume

25.64K

Average Volume (3m)

1-Year Change

Book Value / Share

35.58

Fair Value

Unlock

Fair Value Upside

Unlock

More metrics for 6785

6785 Scorecard

Company’s Health

Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.

Unlock

Fair Value

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.

Unlock Price

Fair Price

Upside

Technical Analysis

Currently not supported.

Analysts Sentiment

Currently not supported.

Members' Sentiments

Bearish

Bullish

ProTips

Tips that distill complex financial data into concise, actionable investment insights.

Unlock All 8

Liquid assets exceed short term obligations

Unlock InvestingPro

Earnings

Latest Release

Aug 13, 2026

EPS / Forecast

0.23 / --

Revenue / Forecast

1.25M / --

EPS Revisions

Unlock

Last 90 days

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS -1.08

Dividend Yield

Industry Median 3.11%

Annualized payout

0.10

Paid annually

5-Years Growth

Growth Streak

Unlock

6785 Income Statement

Compare 6785 to Peers and Sector

Metrics to compare	6785	Peers Peers - average of corresponding metrics from companies closely matching 6785: 6586, 4108, 6919, 6535, 4172	Sector Sector - Average of metrics from a broad group of related Healthcare sector companies	Relationship Relationship6785PeersSector
P/E Ratio	−77.8x	−4.9x	−0.3x
PEG Ratio	0.26	0.38	0.00
Price/Book	2.4x	2.0x	2.6x
Price / LTM Sales	1,870.4x	6.8x	2.8x
Upside (Analyst Target)	-	0.0%	66.6%
Fair Value Upside	Unlock	16.9%	9.1%	Unlock

Alar Pharmaceuticals Inc Company Profile

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.

Industry

Pharmaceuticals

Sector

Healthcare

Market

Taiwan

Ownership

Ownership Overview

Type	Common Stock Held	% of Shares Outstanding	Market Value
Mutual Funds & ETFs	17.00K	0.03%	1.43M
Other Institutional Investors	15.17M	22.71%	1.27B
Public Companies & Retail Investors	51.61M	77.26%	4.34B
Total	66.8M	100.00%	5.61B

Type	Common Stock Held	% of Shares Outstanding	Market Value
Mutual Funds & ETFs	17K	0.03%	1.43M
Other Institutional Investors	15.17M	22.71%	1.27B
Public Companies & Retail Investors	51.61M	77.26%	4.34B
Total	66.8M	100.00%	5.61B

Top Holders

Holder	% of holding	Shares Held	Date Reported	Value (In 1,000s)
CDIB Capital Healthcare Ventures Ltd.	7.94%	5,301,000	Apr 30, 2026	445,284
Fubon Financial Holding Venture Capital Co., Ltd.	4.60%	3,072,000	Mar 03, 2026	258,048

FAQ

What Is the Alar Pharmaceuticals (6785) Stock Price Today?

The Alar Pharmaceuticals stock price today is 84.00 TWD.

What Stock Exchange Does Alar Pharmaceuticals Trade On?

Alar Pharmaceuticals is listed and trades on the Taipei Exchange.

What Is the Stock Symbol for Alar Pharmaceuticals?

The stock symbol for Alar Pharmaceuticals is "6785."

Does Alar Pharmaceuticals Pay Dividends? What’s The Current Dividend Yield?

The Alar Pharmaceuticals dividend yield is 0.1%%.

What Is the Alar Pharmaceuticals Market Cap?

As of today, Alar Pharmaceuticals market cap is 5.61B TWD.

What Is Alar Pharmaceuticals's Earnings Per Share (TTM)?

The Alar Pharmaceuticals EPS (TTM) is -1.08.

When Is the Next Alar Pharmaceuticals Earnings Date?

Alar Pharmaceuticals will release its next earnings report on Nov 05, 2026.

How Many Times Has Alar Pharmaceuticals Stock Split?

Alar Pharmaceuticals has split 0 times.

What is the current trading status of Alar Pharmaceuticals (6785)?

As of Oct 31, 2026, Alar Pharmaceuticals (6785) is trading at a price of 84.00 TWD, with a previous close of 0.00 TWD. The stock has fluctuated within a day range of 82.00 TWD to 85.00 TWD, while its 52-week range spans from 82.00 TWD to 87.50 TWD.

S&P/TSX

35,620.03

-629.00

-1.74%

S&P/TSX 60

2,125.02

-31.76

-1.47%

US 30

51,788.50

-554.1

-1.06%

US 500

7,580.90

-139.3

-1.80%

S&P 500 VIX

19.42

+2.22

+12.91%

DAX

25,818.21

-221.47

-0.85%

Dollar Index

101.83

-0.070

-0.06%

Market Movers

Name	Last	Chg. %	Vol.
RBC	283.93	-1.49%	3.02M
TD	174.04	-2.30%	4.39M
Bank of Montreal	239.22	-2.87%	2.00M
Bank of Nova Scotia	131.05	-1.79%	3.57M
Suncor Energy	111.11	+2.26%	3.70M
Cameco	107.60	-7.74%	3.50M
Imperial Oil	193.48	+5.37%	1.94M

Name	Last	Chg. %	Vol.
Mijem Newcomm Tech	0.10	+375.00%	27.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
Ramm Pharma	0.01	+100.00%	200.00K
Champion Electric	0.010	+100.00%	100.00K
First Growth Funds	0.03	+100.00%	70.00K
Canyon Creek	0.0250	+66.67%	7.00K

Name	Last	Chg. %	Vol.
Modern Plant Based Foods	0.070	-61.11%	2.00K
Regenera Insights	0.03	-54.55%	9.00K
Appili Therapeutics	0.0050	-50.00%	18.01K
James Bay Resources Ltd	0.005	-50.00%	35.10K
SP Strategic Acquisition	0.02	-50.00%	3.00K
Nobel Resources	0.02	-50.00%	51.00K
Playground Ventures	0.005	-50.00%	29.01K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	369.32	-6.77%	623.00K
Air Canada	20.19	-7.68%	5.42M
TD	174.04	-2.30%	4.39M
Space Exploration Tech DRC	22.40	-6.35%	1.76M
Telus	12.37	+2.40%	9.03M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaa Aa	15.50	+58.23%	24.52
Aaaaaaaa Aaaaaa	10.050	+52.84%	15.360
Aaaaa A	37.15	+51.74%	56.37
Aaaaaa Aaaaaa	8.73	+50.57%	13.15
A A A Aaaaaa A	4.60	+49.71%	6.89
Aaaaaaaaaaa Aaaaaaa	20.19	+49.08%	30.10
Aaaaaaaaaaaaaaaaaa	97.88	+46.78%	143.66

Name	Last	Upside	Fair Value
Aaaa Aa	15.50	+58.23%	24.52
Aaaaaaaa Aaaaaa	10.050	+52.84%	15.360
Aaaaa A	37.15	+51.74%	56.37
Aaaaaa Aaaaaa	8.73	+50.57%	13.15
A A A Aaaaaa A	4.60	+49.71%	6.89
Aaaaaaaaaaa Aaaaaaa	20.19	+49.08%	30.10
Aaaaaaaaaaaaaaaaaa	97.88	+46.78%	143.66

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.